The aetiology of rheumatoid arthritis (RA) remains unknown, but the possible role of an infectious agent either as a trigger to the disease, or as a persistent antigenic drive to inflammatory synovitis has not been ruled out. Evidence from laboratory animals has suggested that M tuberculosis could be involved in the pathogenesis of arthritis. Autoimmune arthritis can be induced in MHC susceptible rats by inoculation with M tuberculosis and the disease can be transferred to naive animals by M tuberculosis specific T lymphocyte clones2 from inoculated rats. T cell clones isolated from Lewis rats with adjuvant-induced arthritis have been shown to proliferate in response to the 65 KDa protein of M tuberculosis3 and T lymphocytes of RA patients have been reported to show augmented reactivity to an antigen of M tuberculosis4. IgG and IgA antibodies to the 65 KDa protein ofM tuberculosis in RA are also reported to be significantly higher than in patients with systemic lupus erythematosus, Crohn's disease or healthy controls,5 suggesting that immune responses to the 65 KDa protein may be involved in the initiation or maintenance of RA.
In the present work, we looked for the presence of M tuberculosis in synovial fluid of patients with RA by using the polymerase chain reaction (PCR).
Patients and methods

PATIENTS
Synovial fluid samples from 31 patients fulfilling the American Rheumatism Association Criteria (1987) for definite RA were screened by PCR, for the presence of M tuberculosis DNA. As a comparative group 13 patients (reactive arthritis = 4, psoriatic arthritis = 4, osteoarthritis =2, ankylosing spondylitis =2, gout = 1) were studied. The characteristics of the patients studied are shown in the table.
Synovial fluid was aspirated using an aseptic technique. The needle was removed and the syringe capped, coded and sent to the laboratory within two hours. The cap of the syringe containing synovial fluid was removed in a Category II, laminar flow cabinet, dedicated for this purpose. Synovial fluid was divided into aliquots of 0 5 ml and stored at -700C. EXTRACTION (fig 2) . This shows that the DNA extraction method used in this study removes PCR inhibitors and does not reduce the amplifiability of the DNA template. Seven samples which gave negative result with PCR using primers from APRT gene shows the absence of DNA rather than the presence of PCR inhibitors in amplification reaction. Therefore a negative result in the rest of 37 samples, using the primers for M tuberculosis, would probably be due to absence of M tuberculosis DNA and not to a total lack of DNA.
Persistent infection at sites other than joints can cause reactive arthritis.'6 This possibility has not been excluded by this study. Absence of M tuberculosis DNA in synovial fluid from patients with RA also does not exclude the presence of M tuberculosis DNA in synovial membranes. Although the techniques used in this study could be used to identify the presence of microbial DNA in synovium, it was not considered ethical to collect samples of synovium from the patients included in this study.
Our findings do not support the persistent involvement of M tuberculosis in the aetiopathogenesis of RA. However, its role as a triggering factor in a genetically or otherwise predisposed host cannot be ruled out. 
